Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis.

Immunological investigations - 1 Apr 2018

Gamal Rania M, Gamal Walid M, Ghandour Abeer M, Abozaid Hanan Sayed M, Mohamed Mona Embarek, Emad Yasser, Abdel Galeel Ahmed

Abstract excerpt

OBJECTIVE: we aimed to study systemic sclerosis patients in order to assess osteoprotegerin/Receptor activator of nuclear factor-kB ligand (OPG/RANKL) system and find the relation of these biomarkers with the clinical features of the disease, the carotid intima thickness, markers of inflammation, lipid profile, and other laboratory characteristics. METHODS: both the level of (RANKL), (OPG) in sera of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Cross-Sectional Studies

Share to Inflammation

Share to Osteoprotegerin

Share to RANK Ligand

Share to Scleroderma, Systemic

Source

Identifiers

PMID: 29336616
DOI: 10.1080/08820139.2017.1423499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis.PMID 29336616Read ↗

Systemic sclerosis.Semantic proximity Read ↗

Hands and feet radiologic involvements in systemic sclerosisSemantic proximity Read ↗

[Systemic sclerosis: pathophysiology of a multifaceted disease].Semantic proximity Read ↗

Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.Semantic proximity Read ↗

Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets.Semantic proximity Read ↗

RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.Semantic proximity Read ↗

Estimation of Serum Chemerin, Visfatin Levels and Their Ratio as A Possible Diagnostic Parameters of Rheumatoid ArthritisSemantic proximity Read ↗

Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early diseaseSemantic proximity Read ↗

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis.Semantic proximity Read ↗

Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosisSemantic proximity Read ↗

Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.Semantic proximity Read ↗

Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.